Verastem Oncology grants 399,750 RSUs, sets new-hire stock option exercise price at $4.1

Verastem, Inc.

Verastem, Inc.

VSTM

0.00
  • Verastem granted 399,750 restricted stock units to 30 new employees under an inducement equity award program.
  • One additional new employee received stock options for 91,000 common shares with a $4.1 exercise price set on July 1, 2026.
  • 393,750 RSUs vest 25% after one year, then quarterly over three years; 6,000 RSUs vest in full after one year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verastem Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260702296235) on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.